1391712-60-9

1391712-60-9 structure

Name: CEP-37440
Chemical Name: cep-37440
CAS Number: 1391712-60-9
Molecular Formula: C₃₀H₃₈ClN₇O₃
Molecular Weight: 580.121
Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK ALK
Create Date: 2018-05-08 00:36:23
Modify Date: 2024-01-07 13:31:19
CEP-37440 is a novel potent and selective Dual FAK/ALK inhibitor with IC50 s of 2.3 nM (FAK) and 120 nM(ALK cellular IC50 in 75% human plasma).IC50 value: 2.3 nM (FAK); 120 nM (ALK cellular IC50 in 75% human plasma)Target: Dual FAK/ALKPreparation of fused bicyclic 2,4-diaminopyrimidine derivatives as a dual ALK and FAK inhibitorBy Jacobs, Martin J.; Ott, Gregory R. From PCT Int. Appl. (2013), WO 2013134353 A1 20130912.

Name	cep-37440
Synonyms	2-(5-chloro-2-{(S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylamino}pyrimidin-4-ylamino)-N-methylbenzamide 2-[[5-chloro-2-[[(6S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5Hbenzo[7]annulen-2-yl]amino]pyrimidin-4-yl]amino]-N-methyl-benzamide 2-{[5-Chloro-2-({(6R)-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl}amino)-4-pyrimidinyl]amino}-N-methylbenzamide Benzamide, 2-[[5-chloro-2-[[(6R)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methyl- Benzamide, 2-[[5-chloro-2-[[(6S)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methyl- 2-[[5-chloro-2-[[(6S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-amino]pyrimidin-4-yl]amino]-N-methylbenzamide 2-{[5-Chloro-2-({(6S)-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl}amino)-4-pyrimidinyl]amino}-N-methylbenzamide

Description	CEP-37440 is a novel potent and selective Dual FAK/ALK inhibitor with IC50 s of 2.3 nM (FAK) and 120 nM(ALK cellular IC50 in 75% human plasma).IC50 value: 2.3 nM (FAK); 120 nM (ALK cellular IC50 in 75% human plasma)Target: Dual FAK/ALKPreparation of fused bicyclic 2,4-diaminopyrimidine derivatives as a dual ALK and FAK inhibitorBy Jacobs, Martin J.; Ott, Gregory R. From PCT Int. Appl. (2013), WO 2013134353 A1 20130912.
Related Catalog	Signaling Pathways >> Protein Tyrosine Kinase/RTK >> ALK Signaling Pathways >> Protein Tyrosine Kinase/RTK >> FAK Research Areas >> Cancer
References	[1]. From PCT Int. Appl. (2013), WO 2013134353 A1 20130912. [2]. Salem I, et al. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells. Breast Cancer Res. 2016 Mar 24;18(1):37.